Circulating microRNAs in preterm white matter injury: a systems biology/qPCR-based pilot study

Lolia Ala Ibanibo1, Raúl Montañez-Martínez1, Arantxa Ortega Leon2

  • 1Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital Cádiz, Cádiz, Spain.

Pediatric Research
|March 31, 2026
PubMed
Abstract

Insights

Quantitative PCR (qPCR) combined with systems biology modeling offers a viable method for discovering microRNA (miRNA) biomarkers for white matter injury (WMI) in preterm infants. This approach provides translational insights in challenging neonatal populations.

Area of Science:

  • Neonatal neurology
  • Molecular diagnostics
  • Biomarker discovery

Background:

  • White matter injury (WMI) in preterm infants (PTIs) leads to neurodevelopmental issues, with a need for early molecular biomarkers.
  • Neonatal biosample limitations hinder high-throughput methods like next-generation sequencing (NGS) for biomarker discovery.
  • Quantitative PCR (qPCR) is explored as a primary discovery tool for circulating miRNA biomarkers of WMI.

Purpose of the Study:

  • To evaluate the feasibility of qPCR as a primary discovery tool for circulating miRNA biomarkers of WMI in PTIs.
  • To support qPCR findings with systems biology modeling and selective NGS validation.
  • To identify specific miRNAs and their regulatory roles in WMI pathogenesis.

Main Methods:

  • Plasma miRNAs from PTIs with and without WMI were profiled using qPCR after hemolysis screening.
  • Candidate miRNAs were identified using brain-specific regulatory networks.
  • ROC analysis, gene ontology, and Boolean logic modeling were employed for diagnostic and functional assessment.

Main Results:

  • miR-23a-3p and miR-17-5p showed differential expression and moderate diagnostic power (AUCs 0.71, 0.68).
  • Oligodendrocyte-specific miRNAs were consistently low.
  • Boolean simulations linked miR-23a and miR-17 to oligodendrocyte maturation via PTEN/PI3K/Akt pathways, aligning with qPCR data.

Conclusions:

  • qPCR coupled with systems biology modeling is a viable and sensitive approach for discovering miRNA biomarkers in clinically constrained neonatal populations.
  • This study challenges the default reliance on NGS for biomarker discovery, repositioning qPCR as a powerful primary tool.
  • The integrated approach provides mechanistic insights into WMI pathogenesis by linking specific miRNAs to oligodendrocyte maturation pathways.